danazol has been researched along with griseofulvin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boyd, BJ; Charman, WN; Porter, CJ | 1 |
| Boyd, BJ; Charman, WN; Kaukonen, AM; Porter, CJ | 2 |
| Aso, Y; Furumoto, K; Hayashi, Y; Shiraki, K; Takano, R; Takata, N; Yamashita, S | 1 |
| Bogner, RH; Murdande, SB; Pikal, MJ; Shanker, RM | 1 |
| Decker, H; Hellmann, N; Johnson, R; Khoshakhlagh, P; Langguth, P; Nawroth, T; Schmueser, L; Szekely, NK | 1 |
| Chen, X; Kalantar, TH; Kuo, TC; Ladika, M; Stoneburner, K | 1 |
1 review(s) available for danazol and griseofulvin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for danazol and griseofulvin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Using the polymer partitioning method to probe the thermodynamic activity of poorly water-soluble drugs solubilized in model lipid digestion products.
Topics: Bile Acids and Salts; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Danazol; Diazepam; Fatty Acids; Griseofulvin; Lipids; Micelles; Models, Biological; Pharmaceutical Preparations; Phosphatidylcholines; Polymers; Solubility; Thermodynamics; Water | 2003 |
Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations.
Topics: Cinnarizine; Danazol; Diazepam; Digestion; Griseofulvin; Models, Biological; Pharmaceutical Preparations; Pharmaceutical Solutions; Phenanthrenes; Solubility; Triglycerides; Water | 2004 |
Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.
Topics: Cinnarizine; Danazol; Diazepam; Digestion; Griseofulvin; Pharmaceutical Preparations; Phenanthrenes; Solubility; Suspensions; Triglycerides; Water | 2004 |
Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation.
Topics: Administration, Oral; Animals; Aprepitant; Computer Simulation; Danazol; Dogs; Griseofulvin; Intestinal Absorption; Models, Biological; Morpholines; Nonlinear Dynamics; Particle Size; Permeability; Reproducibility of Results; Solubility; Technology, Pharmaceutical; Water | 2008 |
Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?
Topics: Chemistry, Pharmaceutical; Colloids; Crystallization; Danazol; Griseofulvin; Hypromellose Derivatives; Iopanoic Acid; Kinetics; Light; Methylcellulose; Pharmaceutical Preparations; Povidone; Scattering, Radiation; Solubility; Technology, Pharmaceutical; Ultracentrifugation | 2011 |
Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.
Topics: Body Fluids; Caco-2 Cells; Carbamazepine; Cholesterol; Danazol; Drug Delivery Systems; Fasting; Female; Fenofibrate; Griseofulvin; Humans; Intestinal Absorption; Intestinal Mucosa; Male; Models, Theoretical; Particle Size; Solubility | 2015 |
High-Throughput Raman Spectroscopy Screening of Excipients for the Stabilization of Amorphous Drugs.
Topics: Chemistry, Pharmaceutical; Danazol; Drug Stability; Excipients; Griseofulvin; Ketoprofen; Probucol; Spectrum Analysis, Raman | 2015 |